Andrea is member of the Practice Area Patents Technology & Life Sciences and the Life Sciences & Healthcare Industry Group.

Her practice includes advising national and international pharmaceutical and biotech companies, medical product manufacturers and food product producers on intellectual property law and regulatory issues. A focus of her practice is advising on complex, often cross-border, projects, in particular research and development cooperations, manufacturing and distribution agreements and licences, as well as advice on transactions.

 

显示完整简历 隐藏完整简历

最新新闻和观点

专利与创新

EU Health Technology Assessment (HTA) Regulation (2021/2282) of January 11, 2022.

Background: History of the HTA Regulation

2022年9月12日
Briefing

作者 Dr. Andrea Sautter

点击此处了解更多
数字医疗

Digital Nursing Applications as a further step towards future-oriented health care provision

2022年9月12日
Briefing

作者 Dr. Andrea Sautter

点击此处了解更多
公司/并购与资本市场

Taylor Wessing advises Azenta Life Sciences on the acquisition of the Barkey Group

2022年6月17日

作者

点击此处了解更多
Interface - FoodTech

Innovations in Food Production: EU plans a new legal framework for genome-edited plants

With a new legal framework, the EU is trying to catch up with the state of development of new genomic techniques. At present, they are subject to the rigid regulatory regime of Genetic Engineering Law, and haste is called for.

2022年4月25日
Briefing

作者 Dr. Andrea Sautter

1 / 4 观点

点击此处了解更多

与我会面: